Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

Bishoy A. Gayed, J. Gillen, Alana Christie, Samuel Peña‐Llopis, Xian‐Jin Xie, Jingsheng Yan, José A. Karam, Ganesh V. Raj, Arthur I. Sagalowsky, Yair Lotan,

BMC Urology · 2015 · 43 citations · 23 references

DOIFull text

Open access

Abstract

Our results suggest that ANGPT2 is a marker of RCC. Additionally, ANGPT2 and TuM2PK significantly correlated with several adverse pathological features. Further studies are needed to determine clinical applicability.

References

23